HOME >> BIOLOGY >> NEWS
Clay M. Armstrong, MD, wins 1999 Albert Lasker Basic Medical Research Award

Clay M. Armstrong, MD, professor of physiology at the University of Pennsylvania School of Medicine, will share the 1999 Albert Lasker Basic Medical Research Award from the Albert and Mary Lasker Foundation. Armstrong was named with Bertil Hille, PhD, professor of physiology and biophysics at the University of Washington, and Roderick MacKinnon, MD, professor of molecular neurobiology and biophysics at The Rockefeller University. The researchers will receive their awards during a luncheon on October 1 in New York City.

The Lasker Award is often cited as a Nobel Prize predictor: 61 Lasker Award recipients have subsequently received the honor. Armstrong is being cited for pioneering research elucidating the physical processes underlying electrical signaling in and between cells. His work unveiled the mechanisms governing the behavior of ion channels. These basic components of all cells play a fundamental role in the conduction of electrical impulses in nerve, muscle, and heart, and control the central nervous system, including the brain, muscle contraction, cardiac rhythm, hormone secretion, and many other vital biological events.

Since the 19th century, scientists have known that nerve impulses were transmitted electrically. Exactly how they were propagated throughout the body, however, was still mysterious. During approximately the same era, engineers working on the first trans-Atlantic cables found that electronic signals would fade and be lost without the use of booster stations along the way. What Armstrong discovered years later was precisely how ion channels function as the nervous system's booster stations, responsible for receiving and reproducing signals as they travel along nerve fibers.

"Conveying nerve impulses through the body is like transmitting an electrical signal faithfully over a very long distance," Armstrong explains. "Both require the equivalent of amplifiers along the way. When a signal enters a cell, it doesn't simply pass
'"/>

Contact: Franklin Hoke
hokef@mail.med.upenn.edu
215-349-5659
University of Pennsylvania School of Medicine
26-Sep-1999


Page: 1 2 3

Related biology news :

1. University of Alberta researcher looks for clues to mysterious disease
2. Laser technology to map industrial plant gases available through Alberta Research Council
3. Polar bear headed for extinction, says University of Alberta scientist
4. Rutgers and Albert Einstein College of Medicine researchers seek fountain of youth among the worms
5. Scientists, research advocates honored as Albert B. Sabin Heroes of Science
6. Lasker Award honors Rockefeller University biochemist for pioneering studies of gene activation
7. Basic RNA enzyme research promises single-molecule biosensors
8. Basic motion measuring technology may be alternative to more expensive testing procedures
9. Basic Research and Higher Education Program Conference breaks new ground
10. Cystic Fibrosis Conference Will Showcase Latest From Clinical Care To Basic Science
11. Butterfly Wings, Beetle Horns Teach Biologists Basic Lesson In Developments Laws

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Clay Armstrong wins Albert Lasker Basic Medical Research Award

(Date:10/16/2014)... Cancer constantly wages war on the human body. ... a stalemate. In pancreatic cancer, this stalemate—known as ... becoming aggressively malignant, a phenomena that is poorly ... in the laboratory of Salvatore Torquato, a Professor ... the conditions surrounding tumor dormancy and the switch ...
(Date:10/16/2014)... cultivated efficiently, they are anything but sustainable: environmental ... cultivation is becoming increasingly evident. Despite their disadvantages, ... are regarded as the sole possibility of achieving ... finds Bernhard Schmid, an ecology professor at the ... of agriculture and forestry. After all, a new ...
(Date:10/15/2014)... , Oct. 15, 2014 Sandata Technologies, ... home and community-based care, today announced it released ... Sandata,s Santrax® Electronic Visit Verification™ Solution (EVV™)  for ... a home health company founded in 1996 and ... . The study details the ...
Breaking Biology News(10 mins):Modeling tumor dormancy 2Plant communities produce greater yield than monocultures 2Plant communities produce greater yield than monocultures 3Sandata Announces Case Study with Quality Care Services, Inc. 2
(Date:10/22/2014)... , Oct. 22, 2014 Nuvilex, Inc. ... approximately 400 million people worldwide are living with diabetes, ... people by 2030.  The global market for diabetes treatments ... approximately 330,000 people worldwide died from pancreatic cancer.  Pancreatic ... due to cancer in the United States ...
(Date:10/20/2014)... The report “Pharmacy Automation Systems Market ... Labeling Systems, Table-top Counters) by End-user (Inpatient Pharmacy ... Trends to 2019” analyzes and studies the major ... Europe, Asia-Pacific, and the Rest of the World ... figures spread through 300 pages and in-depth TOC ...
(Date:10/20/2014)... PARK, Calif. , Oct. 20, 2014 /PRNewswire/ ... today that the Company has signed a Notice ... of Regenerative Medicine (CIRM), effective October 1, 2014.  ... Clinical Development payments and the release of additional ... million CIRM grant award for clinical development of ...
(Date:10/20/2014)... Md. , Oct. 20, 2014  GenVec, Inc. (NASDAQ: ... Zola P. Horovitz , Ph.D., from its board of directors ... board in August 2003, and served as its chairman from ... served on the Nominating and Corporate Governance and Audit Committees ... for more than a decade of dedicated service to GenVec, ...
Breaking Biology Technology:Nuvilex Brief Analyst Report: Thinking Outside the Box by BrokerBank Securities, Inc. 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 4Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4Zola P. Horovitz To Retire From GenVec Board 2
Cached News: